To the Editor: Zimmermann and Stewart gave a very interesting survey of the development of acute pain services in Canada. We agree with most of their recommendations for pain therapy on normal wards and their reservations held against the use of epidural opioid analgesia (EOA) especially. Unfortunately, the authors quoted our German questionnaire survey 2 wrongly, i.e., supporting the use of EOA on normal wards. On the contrary, this survey summarized more than 100 cases of severe respiratory depression in 25% of all departments questionned. This was the most frequent potential life-threatening side effect in this survey. Therefore, in accordance with most Canadian anaesthetists, we concluded that the use of EOA may not be recommended Outside of ICU or the recovery room unless very close monitoring of respiration and vigilance is guaranteed. The main argument is the delayed onset of respiratory depression (in contrast to immediate occurrence of hypotension following epidural local anaesthetics). Even the protagonists of EOA on normal wards 3 recommend a respiratory monitor and ICU observations for the first 48 hr for all patients with increased risk (e.g., age >50 yr, ASA status >II, thoracic or upper abdominal surgery). These criteria hold true for most of our patients where epidural analgesia was used. 4 Under these circumstances the continuous infusion of low-dose bupivacaine seems to be a safer alternative, provided that visits to these patients (including neurological examinations) are made by an acute pain service at least once a day. 
